The Board of Directors of Krishna Institute of Medical Sciences Limited (KIMS) has approved a plan to raise capital aggregating up to ₹1,500 Crores. This fundraising will be executed through the issuance of equity shares, potentially via one or more Qualified Institutions Placements (QIP) or other permissible methods. The Board has authorized the Finance & Investment Committee to finalize terms, and a postal ballot notice will be issued to seek shareholder approval for these material transactions.
Key Board Resolutions on Capital Infusion
In a meeting held on 11th March, 2026, the Board of Directors of Krishna Institute of Medical Sciences Limited (KIMS) inter alia approved two significant proposals concerning capital restructuring and shareholder consent.
Proposal 1: Raising Funds Up to ₹1,500 Crores
The primary resolution involved the approval for raising of funds for an aggregate amount up to and not exceeding ₹1,500 Crores (Rupees fifteen hundred crores only). This capital infusion will be done through the issuance of Equity Shares, specifically via one or more Qualified Institutions Placements (“QIP”), or any other permissible mode, in one or more tranches.
The issuance is subject to receiving necessary approvals, including the approval of the members of the Company. The Board has granted authorization to the Finance & Investment Committee to determine the final terms, conditions, and issue price for this fundraising activity.
Proposal 2: Seeking Shareholder Approval
To give effect to the proposed fund raise, the Board formally approved the issuance of a Postal Ballot Notice. This notice will be circulated to the Members in due course to seek their approval via postal ballot regarding the aforesaid matters, in compliance with applicable corporate laws.
Annexure Details: Equity Issuance
The approved disclosure under Annexure A confirms the following parameters for the proposed transaction:
- Type of Securities: Equity Shares.
- Type of Issuance: Qualified Institutions Placements (“QIP”) and/or any other permissible mode.
- Maximum Amount: Not exceeding ₹1,500 Crores, inclusive of any premium fixed.
- Preferential/Bonus/Debt/ADR Issuance: Not applicable to these specific proposals.
The meeting commenced at 12:00 Noon and concluded at 1:20 PM on the date of the announcement.
Source: BSE
